Ledger.Open graph →
SEC Form D · filed March 30, 2020

Xalud Therapeutics, Inc

Offering
$25.1M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BERKELEY, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Sean Stalfort · San Carlos, CADirectorStephen Collins · Nashville, TNExec · DirectorJayson Rieger · San Carlos, CADirectorPaul B. Manning · Berkeley, CADirectorSean Stalfort · San Carlos, CADirectorStephen Collins · St. Petersburg, FLExec · DirectorJayson Rieger · San Carlos, CADirectorPaul B. Manning · Berkeley, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗